|
|
|
 |
|
|
 |
 |
4SC AG
Company
Snapshot Purchase a Full Report on this Company
Business Description:
4SC AG is a Germany-based research-oriented drug discovery and development Company. Its research activities center on cancer and autoimmune indications. The Company develops drug candidates until proof-of-concept in order to generate value creating partnerships with the pharmaceutical industry in return for advance and payments as well as royalties. It collaborates with AiCuris in the field of antiviral and antibacterial drug discovery, with ProQinase to identify a new generation of protein kinase inhibitors in order to develop anticancer drugs, with and ViroLogik in the field of developing, manufacturing and market the compound for viral diseases.
|
|
| |
Wright Quality Rating:
DBNN Rating Explanations |
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
| |
| |
Stock Data: |
Recent Stock Performance: |
|
| |
Current Price (9/3/2010):
2.84
(Figures in
Euro) |
|
1 Week |
2.5% |
|
13 Weeks |
0.6% |
|
|
|
|
|
|
|
|
|
4 Weeks |
-1.7% |
|
52 Weeks |
-4.7% |
|
|
|
| |
| |
4SC AG
Key Data: |
|
|
|
| |
Ticker: |
VSC |
Country: |
GERMANY |
| |
|
| |
Exchanges: |
FRA |
Major Industry: |
Drugs, Cosmetics & Health Care |
| |
|
| |
|
|
Sub Industry: |
Ethical Drug Manufacturers |
| |
|
| |
2009
Sales |
1,861,000
(Year Ending Jan 2010). |
Employees: |
87 |
| |
|
| |
Currency: |
Euro |
Market Cap: |
109,348,520 |
| |
|
| |
Fiscal Yr Ends: |
December |
Shares Outstanding: |
38,503,000 |
| |
|
| |
Share Type: |
Stammaktie |
Closely Held Shares: |
N/A |
|
| |
|
| |
| |
|
|
|
|
| |
Purchase a Full Subscription to All Reports From CorporateInformation: |
|
|
|
| |
The following reports, available for 4SC AG, are typical of the content provided on all companies
covered in CorporateInformation.com
Basic Reports
4SC AG company Profile (Business Description, Price/Earnings, Price/Sales,
Price/Book, Dividend Yield, Company Officers, Contact Information), Competitor Analysis and up to ten-year history of Sales, Earnings per Share,
Dividends per Share, Security Price and Key Ratios. View Samples
Financial Statement Reports
Research reports that analyze 4SC AG Income Statement and Balance Sheet along with
the Sources of Capital for a five-year period. View Samples
Financial Ratio Reports
Analyses reports that highlight 4SC AG
Accounting Ratios, Asset Utilization, Fixed Charges Coverage, Liquidity, Leverage, Profitability,
Employee Efficiency and Per-Share Data over a five-year period. View Samples
Wright Quality Analyses Reports
Wright’s proprietary rating of corporate quality. The reports include a detailed
analysis of 4SC AG Equity, Liquidity, Financial Strength,
Profitability and Corporate Growth. View Samples |
| |
|
|
| |
|
|
|
 |
|
|
|
|
|
|
|
CorporateInformation® website and selected data Copyright © 2000 -
by The Winthrop Corporation. All Rights Reserved. Except for quotations by established
news media, no pages on this site may be reproduced, stored in a retrieval system,
or transmitted for commercial purposes, in any form or by any means, electronic,
mechanical, photocopying, recording, or otherwise without prior written permission.
Information is believed reliable, but accuracy, completeness and opinions are not
guaranteed.
|
|
|
|